-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Excellent Features of qPCR Technology
Author:
InnoModels Biotechnology
Release time:
2024-01-31
Once again demonstrating its leadership in the field of biotechnology, InnoModels Biotechnology has introduced its highly innovative real-time quantitative Polymerase Chain Reaction (qPCR) technology. This technology not only provides scientists with a more accurate and efficient tool for analyzing gene expression, but also opens a new chapter in molecular biology research.
The outstanding features of qPCR technology
1. High sensitivity and specificity:
InnoModels's qPCR technology has excellent sensitivity and specificity, capable of detecting nucleic acid targets at very low concentrations. This high degree of sensitivity allows researchers to accurately quantify the expression level of target genes in very small sample sizes.
2. Real-time monitoring and dynamic analysis:
qPCR technology allows real-time monitoring of the PCR reaction process. By recording real-time fluorescence signals, researchers can obtain data while the reaction is in progress, enabling dynamic analysis of gene expression. This real-time monitoring helps to understand the process of gene expression changes more precisely.
3. Diverse range of applications:
InnoModels's qPCR technology is suitable for a wide range of molecular biology research fields, including gene expression analysis, pathogen detection, mutation analysis and so on. Its wide range of applications provides scientists with the flexibility to conduct efficient experimental design in different research scenarios.
4. Automation and high throughput:
The technology supports automated experimental processes and high-throughput analysis, and can analyze multiple samples at the same time, greatly improving experimental efficiency. This is especially important for research projects such as large-scale genetic screening and high-throughput drug screening.
5. Standardization and reproducibility:
InnoModels Bio's qPCR technology adopts highly standardized experimental protocols to ensure the reproducibility of experiments and stability of results. Researchers can carry out long-term, large-scale research projects with confidence, ensuring the accuracy and reliability of the data.

Scientific Applications and Future Prospects
1. Cancer research:
qPCR technology plays an important role in the expression analysis of cancer-related genes, and is expected to provide more precise molecular information for cancer diagnosis and the development of treatment strategies.
2. Infection virus detection:
In the field of pathogen detection, the high sensitivity and specificity of qPCR technology make it an ideal choice for detecting infectious viruses, and is expected to play a key role in infectious disease research and clinical detection.
3. drug discovery and development:
The high throughput and automation features of qPCR technology help accelerate the drug development process, providing an efficient tool for new drug screening and efficacy assessment.
Conclusion
Thanks to its excellent features, qPCR technology from InnoModels Biotechnology is leading the way in molecular biology research. This technology is widely used and not only plays a key role in basic science research, but also provides strong support for clinical medicine and drug discovery. With the continuous upgrading and innovation of the technology, InnoModels Biotechnology is expected to continue to lead the development of qPCR technology, and to promote more in-depth and extensive breakthroughs in scientific research.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd